Genome-based in silico identification of new Mycobacterium tuberculosis antigens activating polyfunctional CD8+ T cells in human tuberculosis

Journal of Immunology

Volumn 186, Issue 2, 2011, Pages 1068-1080

  Tang, Sheila T ^a   Van Meijgaarden, Krista E ^b   Caccamo, Nadia ^c   Guggino, Giuliana ^c   Klein, Michèl R ^b,g   Van Weeren, Pascale ^b   Kazi, Fatima ^b   Stryhn, Anette ^d,e   Zaigler, Alexander ^f   Sahin, Ugur ^f   Buus, Søren ^d,e   Dieli, Francesco ^c   Lund, Ole ^a   Ottenhoff, Tom H M ^b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f Ganymed Pharmaceuticals   (Germany)

^g NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B7 ANTIGEN; INTERLEUKIN 2; MYCOBACTERIUM ANTIGEN; TETRAMER; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CD8+ T LYMPHOCYTE; COMPUTER MODEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

ADULT; AGED; ANTIGENS, BACTERIAL; CD8-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; EPITOPES, T-LYMPHOCYTE; FEMALE; GENOME, BACTERIAL; GENOME, HUMAN; HUMANS; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; TUBERCULOSIS;

EID: 79251578349     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002212     Document Type: Article

References (63)

1. World Health Organization. 2008. WHO Report 2008: Global Tuberculosis Control - Surveillance, Planning, Financing. World Health Organization, Geneva, Switzerland.
2. Ottenhoff, T. H. 2009. Overcoming the global crisis: "yes, we can", but also for TB ...? Eur. J. Immunol. 39: 2014-2020.
3. Raviglione, M. C., and I. M. Smith. 2007. XDR tuberculosis - implications for global public health. N. Engl. J. Med. 356: 656-v659.
4. Shah, N. S., A. Wright, G. H. Bai, L. Barrera, F. Boulahbal, N. Martín-Casabona, F. Drobniewski, C. Gilpin, M. Havelková, R. Lepe, et al. 2007. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13: 380-387.
5. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162: 5407-5416.
6. Pathan, A. A., K. A. Wilkinson, P. Klenerman, H. McShane, R. N. Davidson, G. Pasvol, A. V. Hill, and A. Lalvani. 2001. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosisinfected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167: 5217-5225.
7. Wallace, J. M., N. I. Hansen, L. Lavange, J. Glassroth, B. L. Browdy, M. J. Rosen, P. A. Kvale, B. T. Mangura, L. B. Reichman, P. C. Hopewell; Pulmonary Complications of HIV Infection Study Group. 1997. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Am. J. Respir. Crit. Care Med. 155: 72-80.
8. Ab, B. K., R. Kiessling, J. D. Van Embden, J. E. Thole, D. S. Kumararatne, P. Pisa, A. Wondimu, and T. H. Ottenhoff. 1990. Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein. Eur. J. Immunol. 20: 369-377.
9. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89: 12013-12017.
10. Kamath, A. B., J. Woodworth, X. Xiong, C. Taylor, Y. Weng, and S. M. Behar. 2004. Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J. Exp. Med. 200: 1479-1489.
11. Pathan, A. A., K. A. Wilkinson, R. J. Wilkinson, M. Latif, H. McShane, G. Pasvol, A. V. Hill, and A. Lalvani. 2000. High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class Irestricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur. J. Immunol. 30: 2713-2721.
12. McShane, H., S. Behboudi, N. Goonetilleke, R. Brookes, and A. V. Hill. 2002. Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A. Infect. Immun. 70: 1623-1626.
13. Klein, M. R., S. M. Smith, A. S. Hammond, G. S. Ogg, A. S. King, J. Vekemans, A. Jaye, P. T. Lukey, and K. P. McAdam. 2001. HLA-B*35- restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis. J. Infect. Dis. 183: 928-934.
14. Smith, S. M., R. Brookes, M. R. Klein, A. S. Malin, P. T. Lukey, A. S. King, G. S. Ogg, A. V. Hill, and H. M. Dockrell. 2000. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J. Immunol. 165: 7088-7095.
15. Caccamo, N., G. Guggino, S. Meraviglia, G. Gelsomino, P. Di Carlo, L. Titone, M. Bocchino, D. Galati, A. Matarese, J. Nouta, et al. 2009. Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection. PLoS ONE 4: e5528.
16. Cho, S., V. Mehra, S. Thoma-Uszynski, S. Stenger, N. Serbina, R. J. Mazzaccaro, J. L. Flynn, P. F. Barnes, S. Southwood, E. Celis, et al. 2000. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc. Natl. Acad. Sci. USA 97: 12210-12215.
17. Kaufmann, S. H., and A. J. McMichael. 2005. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat. Med. 11(4 Suppl): S33-S44.
18. Lalvani, A., R. Brookes, R. J.Wilkinson, A. S. Malin, A. A. Pathan, P. Andersen, H. Dockrell, G. Pasvol, and A. V. Hill. 1998. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95: 270-275.
19. Klein, M. R., and A. Fox. 2001. Mycobacterium-specific human CD8 T cell responses. Arch. Immunol. Ther. Exp. (Warsz.) 49: 379-389.
20. Ottenhoff, T. H. M., D. A. Lewinsohn, and D. M. Lewinsohn. 2008. Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis: Antigen Specificity, Function, Implications and Applications. Wiley-VCH Verlag GmbH, Weinheim, Germany.
21. Stenger, S., R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J. P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, and R. L. Modlin. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276: 1684-1687.
22. Tully, G., C. Kortsik, H. Höhn, I. Zehbe, W. E. Hitzler, C. Neukirch, K. Freitag, K. Kayser, and M. J. Maeurer. 2005. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J. Immunol. 174: 2174-2184.
23. Gambón-Deza, F., M. Pacheco Carracedo, T. Cerdá Mota, and J. Montes Santiago. 1995. Lymphocyte populations during tuberculosis infection: V beta repertoires. Infect. Immun. 63: 1235-1240.
24. Caccamo, N., S. Meraviglia, C. La Mendola, G. Guggino, F. Dieli, and A. Salerno. 2006. Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J. Immunol. 177: 1780-1785.
25. Jacobsen, M., A. K. Detjen, H. Mueller, A. Gutschmidt, S. Leitner, U. Wahn, K. Magdorf, and S. H. Kaufmann. 2007. Clonal expansion of CD8+ effector T cells in childhood tuberculosis. J. Immunol. 179: 1331-1339.
26. Lewinsohn, D. A., E. Winata, G. M. Swarbrick, K. E. Tanner, M. S. Cook, M. D. Null, M. E. Cansler, A. Sette, J. Sidney, and D. M. Lewinsohn. 2007. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog. 3: 1240-1249.
27. Geluk, A., K. E. van Meijgaarden, K. L. Franken, J. W. Drijfhout, S. D'Souza, A. Necker, K. Huygen, and T. H. Ottenhoff. 2000. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A* 0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J. Immunol. 165: 6463-6471.
28. Leyten, E. M., M. Y. Lin, K. L. Franken, A. H. Friggen, C. Prins, K. E. van Meijgaarden, M. I. Voskuil, K. Weldingh, P. Andersen, G. K. Schoolnik, et al. 2006. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 8: 2052-2060.
29. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry, III et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
30. Blythe, M. J., Q. Zhang, K. Vaughan, R. de Castro, Jr., N. Salimi, H. H. Bui, D. M. Lewinsohn, J. D. Ernst, B. Peters, and A. Sette. 2007. An analysis of the epitope knowledge related to Mycobacteria. Immunome Res. 3: 10.
31. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50: 201-212.
32. Larsen, M. V., C. Lundegaard, K. Lamberth, S. Buus, S. Brunak, O. Lund, and M. Nielsen. 2005. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur. J. Immunol. 35: 2295-2303.
33. Yusim, K., C. Kesmir, B. Gaschen, M. M. Addo, M. Altfeld, S. Brunak, A. Chigaev, V. Detours, and B. T. Korber. 2002. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J. Virol. 76: 8757-8768.
34. Welsh, R. M., and R. S. Fujinami. 2007. Pathogenic epitopes, heterologous immunity and vaccine design. Nat. Rev. Microbiol. 5: 555-563.
35. Voskuil, M. I., K. C. Visconti, and G. K. Schoolnik. 2004. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb.) 84: 218-227.
36. Ottenhoff, T. H., J. B. Haanen, A. Geluk, T. Mutis, B. K. Ab, J. E. Thole, W. C. van Schooten, P. J. van den Elsen, and R. R. de Vries. 1991. Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy. Immunol. Rev. 121: 171-191.
37. Mustafa, A. S. 2001. Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. Curr. Pharm. Biotechnol. 2: 157-173.
38. Wiker, H. G., M. A. Wilson, and G. K. Schoolnik. 2000. Extracytoplasmic proteins of Mycobacterium tuberculosis - mature secreted proteins often start with aspartic acid and proline. Microbiology 146: 1525-1533.
39. Bendtsen, J. D., L. Kiemer, A. Fausbøll, and S. Brunak. 2005. Non-classical protein secretion in bacteria. BMC Microbiol. 5: 58.
40. Sylvester-Hvid, C., N. Kristensen, T. Blicher, H. Ferré, S. L. Lauemøller, X. A. Wolf, K. Lamberth, M. H. Nissen, L. O. Pedersen, and S. Buus. 2002. Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction. Tissue Antigens 59: 251-258.
41. Leisner, C., N. Loeth, K. Lamberth, S. Justesen, C. Sylvester-Hvid, E. G. Schmidt, M. Claesson, S. Buus, and A. Stryhn. 2008. One-pot, mix-and-read peptide-MHC tetramers. PloS One 3: e1678.
42. Armitage, P., G. Berry, and J. N. S. Matthews. 2002. Statistical Methods in Medical Research. Blackwell Science, Hoboken, NJ.
43. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153: 5586-5592.
44. Joosten, S. A., K. E. van Meijgaarden, P. C. van Weeren, F. Kazi, A. Geluk, N. D. Savage, J. W. Drijfhout, D. R. Flower, W. A. Hanekom, M. R. Klein, and T. H. Ottenhoff. 2010. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. PLoS Pathog. 6: e1000782.
45. Seder, R. A., P. A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8: 247-258.
46. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17: 51-88.
47. Dietrich, J., C. Aagaard, R. Leah, A. W. Olsen, A. Stryhn, T. M. Doherty, and P. Andersen. 2005. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J. Immunol. 174: 6332-6339. (Pubitemid 40663826)
48. Horwitz, M. A., G. Harth, B. J. Dillon, and S. Maslesa-Galic. 2005. Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein. Infect. Immun. 73: 4676-4683.
49. Olsen, A. W., A. Williams, L. M. Okkels, G. Hatch, and P. Andersen. 2004. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect. Immun. 72: 6148-6150.
50. Roupie, V., M. Romano, L. Zhang, H. Korf, M. Y. Lin, K. L. Franken, T. H. Ottenhoff, M. R. Klein, and K. Huygen. 2007. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect. Immun. 75: 941-949.
51. Skeiky, Y. A., M. R. Alderson, P. J. Ovendale, J. A. Guderian, L. Brandt, D. C. Dillon, A. Campos-Neto, Y. Lobet, W. Dalemans, I. M. Orme, and S. G. Reed. 2004. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J. Immunol. 172: 7618-7628.
52. Dong, Y., S. Demaria, X. Sun, F. R. Santori, B. M. Jesdale, A. S. De Groot, W. N. Rom, and Y. Bushkin. 2004. HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infect. Immun. 72: 2412-2415.
53. Flyer, D. C., V. Ramakrishna, C. Miller, H. Myers, M. McDaniel, K. Root, C. Flournoy, V. H. Engelhard, D. H. Canaday, J. A. Marto, et al. 2002. Identification by mass spectrometry of CD8(+)-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product. Infect. Immun. 70: 2926-2932.
54. Hammond, A. S., M. R. Klein, T. Corrah, A. Fox, A. Jaye, K. P. McAdam, and R. H. Brookes. 2005. Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes. Clin. Exp. Immunol. 140: 109-116.
55. Lewinsohn, D. A., R. A. Lines, and D. M. Lewinsohn. 2002. Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis - specific CD8+ T cells. Am. J. Respir. Crit. Care Med. 166: 843-848.
56. Marmiesse, M., P. Brodin, C. Buchrieser, C. Gutierrez, N. Simoes, V. Vincent, P. Glaser, S. T. Cole, and R. Brosch. 2004. Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. Microbiology 150: 483-496.
57. Mohagheghpour, N., D. Gammon, L. M. Kawamura, A. van Vollenhoven, C. J. Benike, and E. G. Engleman. 1998. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J. Immunol. 161: 2400-2406.
58. Bihl, F., N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, et al. 2006. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 176: 4094-4101.
59. Vani, J., M. S. Shaila, N. R. Chandra, and R. Nayak. 2006. A combined immuno-informatics and structure-based modeling approach for prediction of T cell epitopes of secretory proteins of Mycobacterium tuberculosis. Microbes Infect. 8: 738-746.
60. Pasquetto, V., H. H. Bui, R. Giannino, C. Banh, F. Mirza, J. Sidney, C. Oseroff, D. C. Tscharke, K. Irvine, J. R. Bennink, et al. 2005. HLA-A*0201, HLA-A* 1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. [Published erratum appears in 2005 J. Immunol 175: 8440.] J. Immunol. 175: 5504-5515. (Pubitemid 41456438)
61. Assarsson, E., J. Sidney, C. Oseroff, V. Pasquetto, H. H. Bui, N. Frahm, C. Brander, B. Peters, H. Grey, and A. Sette. 2007. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J. Immunol. 178: 7890-7901. (Pubitemid 46898061)
62. Tang, S. T., M. Wang, K. Lamberth, M. Harndahl, M. H. Dziegiel, M. H. Claesson, S. Buus, and O. Lund. 2008. MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination. Arch. Virol. 153: 1833-1844.
63. Caccamo, N., G. Guggino, S. A. Joosten, G. Gelsomino, P. Di Carlo, L. Titone, D. Galati, M. Bocchino, A. Matarese, A. Salerno, et al. 2010. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur. J. Immunol. 40: 2211-2220.